AeroShot Caffeine Inhaler Scrutinized By FDA
The U.S. Food and Drug Administration sent a warning letter Monday to the makers of the controversial AeroShot caffeine inhaler, saying the product is mislabeled and could be dangerous to users'...To view the full article, register now.
Already a subscriber? Click here to view full article